What Is an Endocrinologist? All About Hormone Doctors

What Exactly Does an Endocrinologist Do?

An endocrinologist is a physician trained to evaluate, diagnose, and treat disorders of the endocrine glands: structures that secrete hormones directly into the bloodstream. These include the thyroid, parathyroid glands, adrenal glands, pancreas, pituitary gland, ovaries, and testes. Because hormones regulate metabolism, growth, reproduction, sleep, mood, and fluid balance, a malfunction in any one gland can produce wide-ranging symptoms across multiple organ systems.

The American Association of Clinical Endocrinology (AACE) describes endocrinology as covering "the diagnosis and treatment of diseases related to hormones," with a clinical scope that spans more than 100 distinct disorders. AACE clinical guidelines are available at aace.com.

The Diagnostic Process

Diagnosis in endocrinology depends on laboratory testing far more than most specialties. A patient presenting with fatigue and weight gain might leave a primary care appointment with basic thyroid-stimulating hormone (TSH) screening. An endocrinologist, by contrast, may order a full thyroid panel including free T4, free T3, reverse T3, and thyroid antibodies (anti-TPO, anti-thyroglobulin) to characterize the precise mechanism of dysfunction. Reference ranges and clinical interpretation are detailed in the NIH's thyroid function testing resource.

Dynamic Testing

Some endocrine diagnoses require dynamic tests. A patient suspected of having Cushing syndrome, for instance, undergoes a 1 mg overnight dexamethasone suppression test: a normal cortisol response of <1.8 mcg/dL after dexamethasone administration effectively rules out the diagnosis in most outpatient cases. A 2022 Endocrine Society guideline update published in the Journal of Clinical Endocrinology and Metabolism confirms this threshold.

Treatment Approaches

Treatment tools available to endocrinologists include:

• Thyroid hormone replacement (levothyroxine, liothyronine)
• Insulin regimens and GLP-1 receptor agonists (semaglutide, tirzepatide)
• Steroid hormone replacement for adrenal insufficiency (hydrocortisone, fludrocortisone)
• Testosterone replacement therapy (TRT) for hypogonadism
• Antithyroid medications (methimazole, propylthiouracil) for hyperthyroidism
• Bisphosphonates and RANK-L inhibitors for osteoporosis
• Dopamine agonists (cabergoline) for prolactin-secreting pituitary adenomas

Endocrinologist vs. Primary Care: What Is the Difference?

Primary care physicians manage the majority of endocrine conditions at a population level. They initiate thyroid screening, prescribe first-line diabetes medications, and adjust levothyroxine doses for stable hypothyroidism. An endocrinologist becomes necessary when a condition is newly diagnosed and complex, refractory to standard therapy, or carries diagnostic uncertainty.

The American Diabetes Association (ADA) Standards of Medical Care in Diabetes (2024 edition) specifically recommends endocrinology referral "when glycemic targets are not met after 3-6 months of optimized therapy or when the diagnosis of diabetes type is uncertain." The full ADA 2024 Standards are available at diabetesjournals.org.

When a Generalist Is Enough

A person with stable, well-controlled hypothyroidism on a fixed levothyroxine dose, with TSH consistently within the 0.4-4.0 mIU/L reference range, typically does not require ongoing endocrinology follow-up. Annual TSH monitoring by a primary care provider is sufficient per Endocrine Society guidelines. See the 2014 Endocrine Society Clinical Practice Guideline on hypothyroidism.

When You Need the Specialist

Referral becomes appropriate in several scenarios:

• Type 1 diabetes at any age. Managing autoimmune beta-cell destruction, insulin-to-carbohydrate ratios, continuous glucose monitoring interpretation, and hybrid closed-loop systems requires specialized training.
• Thyroid nodules. The 2015 American Thyroid Association (ATA) guidelines recommend fine-needle aspiration biopsy for nodules meeting specific ultrasound criteria, a decision best made by or in consultation with a specialist. ATA guidelines are available via pubmed.ncbi.nlm.nih.gov.
• Adrenal incidentaloma. Adrenal masses discovered incidentally on CT imaging require a structured hormonal work-up to exclude pheochromocytoma, primary aldosteronism, and cortisol excess.
• Osteoporosis with fragility fracture. A hip or spine fracture on minimal trauma demands specialist assessment of secondary causes and selection among anabolic versus antiresorptive therapies.

Which Conditions Does an Endocrinologist Treat?

Endocrinologists manage a broad set of diagnoses. The following are the highest-volume conditions seen in outpatient endocrinology practices across the United States.

Diabetes Mellitus

Diabetes is by far the most common reason patients see an endocrinologist. The CDC reports that 38.4 million Americans (11.6% of the population) have diabetes as of 2023, with Type 2 diabetes accounting for approximately 90-95% of cases. Source: CDC National Diabetes Statistics Report, 2024.

Endocrinologists prescribe GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). In the STEP-1 trial (N=1,961), once-weekly subcutaneous semaglutide 2.4 mg produced a mean weight loss of 14.9% over 68 weeks versus 2.4% with placebo (P<0.001). STEP-1 full publication is available on nejm.org. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg produced a mean reduction of 20.9% body weight at 72 weeks versus 3.1% placebo. SURMOUNT-1 is available at nejm.org.

Thyroid Disorders

Hypothyroidism affects approximately 4.6% of the U.S. Population aged 12 and older, based on NHANES data analyzed by Aoki et al. And published in the Archives of Internal Medicine. Hyperthyroidism affects roughly 1.2% of the same population. PubMed record for Aoki et al. 2007 NHANES thyroid analysis.

Endocrinologists differentiate among Hashimoto thyroiditis, Graves disease, subacute thyroiditis, and toxic multinodular goiter. Treatment decisions depend on radioactive iodine uptake scans, thyroid antibody titers, and ultrasound characteristics.

Adrenal Disorders

Primary adrenal insufficiency (Addison disease) has a prevalence of roughly 100-140 cases per million in Western populations, making it rare but potentially life-threatening without appropriate glucocorticoid and mineralocorticoid replacement. A comprehensive review is indexed at pubmed.ncbi.nlm.nih.gov.

Cushing syndrome, primary hyperaldosteronism (Conn syndrome), and pheochromocytoma round out the adrenal conditions most commonly managed by endocrinologists.

Reproductive and Sex Hormone Disorders

Polycystic ovary syndrome (PCOS) affects 6-12% of reproductive-age women in the United States and is a leading cause of anovulatory infertility, according to the CDC. CDC PCOS data are available at cdc.gov. Endocrinologists often co-manage PCOS with gynecologists, addressing insulin resistance, androgen excess, and ovulation induction.

Male hypogonadism, characterized by serum total testosterone below 300 ng/dL on two morning measurements (per the AUA 2018 guideline), is another condition where endocrinologists provide testosterone replacement therapy evaluation and monitoring. AUA guideline summary is indexed at pubmed.ncbi.nlm.nih.gov.

Pituitary Disorders

The pituitary gland, often called the "master gland," secretes hormones that control the thyroid, adrenal glands, and gonads. Pituitary adenomas, which are almost always benign, occur in roughly 1 in 1,000 people based on autopsy series. Growth hormone excess (acromegaly), prolactin excess (hyperprolactinemia), and panhypopituitarism after pituitary surgery all fall under endocrinology management. A PubMed review of pituitary adenoma epidemiology is available here.

Osteoporosis and Metabolic Bone Disease

Endocrinologists evaluate bone mineral density via DEXA scan, calculate FRAX 10-year fracture risk scores, and prescribe therapy. The Endocrine Society's 2019 guideline recommends pharmacologic therapy for postmenopausal women with a FRAX 10-year hip fracture probability of 3% or greater, or a major osteoporotic fracture probability of 20% or greater. The 2019 Endocrine Society osteoporosis guideline is indexed at pubmed.ncbi.nlm.nih.gov.

How Are Endocrinologists Trained?

Training is long. It begins with a four-year medical school degree (M.D. Or D.O.), followed by a three-year internal medicine residency (or pediatric residency for pediatric endocrinologists). After residency, physicians complete a two-to-three-year endocrinology, diabetes, and metabolism fellowship accredited by the Accreditation Council for Graduate Medical Education (ACGME). ACGME program requirements are published at acgme.org.

Board certification requires passing the American Board of Internal Medicine (ABIM) endocrinology examination. Maintenance of certification involves passing recertification exams every 10 years along with ongoing continuing medical education requirements.

Pediatric Endocrinology

Pediatric endocrinologists complete a pediatric residency and then a three-year pediatric endocrinology fellowship. They manage Type 1 diabetes, growth hormone deficiency, precocious puberty, congenital hypothyroidism (detected via newborn screening), and disorders of sexual development. The American Academy of Pediatrics endorses universal newborn TSH screening, which has nearly eliminated intellectual disability from untreated congenital hypothyroidism in the United States. AAP newborn screening position is referenced in this NIH resource.

Subspecialties Within Endocrinology

Some endocrinologists pursue additional focus areas:

• Thyroidology: Thyroid cancer surveillance, radioactive iodine therapy dosing, molecular marker interpretation from fine-needle aspiration
• Reproductive endocrinology: Distinct from ob-gyn reproductive endocrinology; focuses on PCOS, hypogonadism, and transgender hormone therapy
• Obesity medicine: A growing number of endocrinologists obtain additional certification from the American Board of Obesity Medicine (ABOM) to provide comprehensive weight management
• Bone and mineral metabolism: Focused on osteoporosis, vitamin D disorders, hypo- and hyperparathyroidism

What Happens at Your First Endocrinology Appointment?

The first visit is typically 45-90 minutes. Bringing all prior labs, imaging reports, a complete medication list (including supplements), and a timeline of symptom onset significantly improves the efficiency of the consultation.

History and Physical Exam

Endocrinologists take a detailed history focused on symptom pattern, family history of thyroid disease or diabetes, medication exposures (including lithium, amiodarone, and corticosteroids, which affect hormone axes), and reproductive history. Physical exam includes thyroid palpation, assessment of skin and hair changes, blood pressure, body weight, and in some cases visual field testing for suspected pituitary adenoma.

Laboratory Orders

Expect an expanded lab panel. For a thyroid referral, this may include TSH, free T4, free T3, anti-TPO antibodies, and thyroglobulin. For an adrenal referral, 24-hour urinary free cortisol, late-night salivary cortisol, and plasma metanephrines may be ordered. The Endocrine Society's clinical practice guideline on Cushing syndrome diagnosis outlines these tests in detail.

Imaging

Thyroid ultrasound is the primary imaging modality for thyroid nodule characterization and uses the ACR TIRADS (Thyroid Imaging Reporting and Data System) scoring system. DEXA scan is standard for bone density assessment. MRI of the pituitary (with gadolinium contrast) is used when a pituitary adenoma is suspected based on hormone levels or visual symptoms.

Endocrinologists and Hormone Therapy: TRT, HRT, and GLP-1 Medications

Hormone therapy is a core domain of endocrinology practice. Three categories generate the highest patient interest at present.

Testosterone Replacement Therapy (TRT)

TRT is indicated for men with symptomatic hypogonadism confirmed by two early-morning serum total testosterone measurements below 300 ng/dL, per the 2018 AUA guideline. AUA guideline indexed at pubmed.ncbi.nlm.nih.gov. Available formulations include intramuscular testosterone cypionate (typically 100-200 mg every 1-2 weeks), testosterone enanthate, topical gels (AndroGel 1%, 1.62%; Testim), transdermal patches, subcutaneous pellets, and the nasal gel Natesto. Endocrinologists monitor hematocrit (target <54%), PSA, and symptom response at 3 and 6 months after initiation, then annually.

Menopausal Hormone Replacement Therapy (HRT)

The Menopause Society (formerly NAMS) 2022 position statement affirms that for women under 60 or within 10 years of menopause onset, the benefits of hormone therapy for bothersome vasomotor symptoms outweigh risks in the absence of contraindications. The 2022 Menopause Society position statement is available at menopause.org. Endocrinologists prescribe estradiol (oral, transdermal patch, gel, or spray) combined with micronized progesterone (Prometrium 200 mg for 12 days per cycle, or 100 mg daily continuous) in women with an intact uterus.

GLP-1 Receptor Agonists for Weight Management

The decision to prescribe a GLP-1 receptor agonist for weight management follows a structured framework used by HealthRX-affiliated endocrinologists:

1. Confirm indication. BMI of 30 or greater, or BMI of 27 or greater with at least one weight-related comorbidity (Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea).
2. Screen for contraindications. Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2) contraindicates semaglutide and tirzepatide based on FDA prescribing information.
3. Select agent. Semaglutide 2.4 mg weekly (Wegovy) for obesity; tirzepatide 15 mg weekly (Zepbound) when added efficacy is desired. FDA approval announcement for Wegovy is at accessdata.fda.gov.
4. Titrate slowly. Semaglutide starts at 0.25 mg weekly for 4 weeks before the first dose escalation.
5. Monitor. Thyroid function, renal function, and gastrointestinal tolerability at each follow-up.

The FDA approved semaglutide 2.4 mg (Wegovy) for chronic weight management in June 2021 and tirzepatide (Zepbound) in November 2023. FDA Zepbound approval is at accessdata.fda.gov.

When Should You Ask Your Primary Care Doctor for an Endocrinology Referral?

The most direct answer: ask when your current treatment is not working, when your diagnosis is uncertain, or when test results are complex enough that your primary care provider requests specialist input.

Specific triggers include:

• HbA1c above 8% despite three or more diabetes medications
• TSH below 0.1 mIU/L or above 10 mIU/L on repeat testing
• A thyroid nodule detected on any imaging
• Suspected Cushing syndrome (central weight gain, purple striae, proximal muscle weakness, uncontrolled hypertension)
• Testosterone below 300 ng/dL with symptoms (low libido, fatigue, reduced muscle mass) on two separate morning draws
• Unexplained hypercalcemia (serum calcium above 10.5 mg/dL on repeat measurement)
• Bone density T-score of -2.5 or lower (osteoporosis) or a fragility fracture at any T-score
• Suspected pheochromocytoma (episodic hypertension, headache, diaphoresis, palpitations)

The Endocrine Society's clinical practice guideline on primary hyperparathyroidism states: "We recommend that all patients with asymptomatic primary hyperparathyroidism be evaluated jointly by an endocrinologist and a surgeon experienced in parathyroid surgery to determine the most appropriate management." Endocrine Society 2022 primary hyperparathyroidism guideline is indexed at pubmed.ncbi.nlm.nih.gov.

How to Find and Evaluate an Endocrinologist

The AACE physician finder and the Endocrine Society's "Find an Endocrinologist" tool are the two primary directories. When evaluating a provider, confirm:

• Board certification in endocrinology, diabetes, and metabolism via the ABIM website
• Fellowship completion at an ACGME-accredited program
• Experience with your specific condition (a pituitary specialist and a diabetes specialist have different day-to-day practice patterns)
• Whether the practice accepts your insurance and offers telehealth for follow-up visits

Telehealth has expanded access substantially since 2020. A 2021 analysis published in JAMA Network Open found that endocrinology had one of the highest rates of telemedicine adoption among medical specialties during the COVID-19 period, with visit volume recovering to pre-pandemic levels faster via telehealth than in-person. JAMA Network Open endocrinology telemedicine analysis.

A shortage of endocrinologists relative to demand is well-documented. The Endocrine Society projects that by 2025, the United States will face a shortage of approximately 1,500-2,000 endocrinologists needed to meet population demand for diabetes and metabolic disease alone. Endocrine Society workforce report referenced at endocrine.org. This gap reinforces the role of telehealth platforms and collaborative care models in extending specialist access.